Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
**Background:** Huntington’s disease (HD) is a multifaceted neurodegenerative disorder characterized by involuntary movements, specifically chorea, as well as behavioral and psychiatric disturbance, and cognitive dysfunction. Tetrabenazine was the first approved treatment for chorea, although tolera...
Saved in:
Main Authors: | Victor W. Sung, Sanjay K. Gandhi, Victor Abler, Brian Davis, Debra E. Irwin, Karen E. Anderson, Ravi G. Iyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2018-01-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9779 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
deutetrabenazine for the treatment of chorea associated with Huntington’s disease
by: Harshit Gupta, et al.
Published: (2022-06-01) -
Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease
by: Daniel O. Claassen, et al.
Published: (2021-06-01) -
Coexistence of Gait Disturbances and Chorea in Experimental Huntington’s Disease
by: João Casaca-Carreira, et al.
Published: (2015-01-01) -
Chorea as the First and Only Manifestation of Systemic Lupus Erythematosus
by: Abdul Razzakh Poil, et al.
Published: (2012-01-01) -
Chorea Hyperglycemia Basal Ganglia Syndrome in a 63-Year-Old Male
by: Michael Sperling, et al.
Published: (2018-01-01)